Reduced S100A4 expression increases the probability of DMFS of breast cancer patients with a lymph node positive status but shows a higher FDR (Figure 5B; dataset 203186_s_at; n = 382; FDR > 50%; P = 0.024, cut-off values see Figure 5, Figure S6). This evidence concerns the gene S100A4 and breast carcinoma.